
Switzerland
Directory


5Gambit Disputes Ltd

Aceris Law

ADB Altorfer Duss & Beilstein

Advestra

Aegis Partners LLC

Alliance of Business Lawyers (ABL)

ALTENBURGER LTD legal + tax

Baker McKenzie AG

Bär & Karrer Ltd.

Barandun AG

Belluzzo International Partners

Bersheda Law
Binder Legal KLG

Blesi & Papa

Bonnard Lawson

Bratschi Ltd
Buis Bürgi AG
burckhardt Ltd

Chabrier Avocats

Charles Russell Speechlys AG

CMS von Erlach Partners Ltd.

Dentons

Faerus

FBT Attorneys-at-Law

Fischer Ramp Buchmann

Fortior Law

Gabriel Arbitration AG

gbf Attorneys-at-law Ltd

GGI | Global Alliance

Gillioz Dorsaz & Associés

Hafner Urbach Partner

HFW

Homburger

Id Est Avocats Sàrl

Kaiser Odermatt & Partner

Kellerhals Carrard

King & Spalding LLP

LALIVE

Lenz & Staehelin

LKK Arbitration

LNI Legal Network International

Loyens & Loeff

Ludwig + Partner Ltd.

Lustenberger + Partners

MLL Legal

MME Legal | Tax | Compliance

Nater Dallafior Rechtsanwälte AG

Niederer Kraft Frey Ltd

Niedermann Rechtsanwälte

OBERSON ABELS SA

Orrick, Herrington & Sutcliffe LLP

Patocchi & Marzolini

Pestalozzi

Peter & Kim

Prager Dreifuss AG

Quinn Emanuel Urquhart & Sullivan (Schweiz) GmbH

Riedweg & Partner AG

Schellenberg Wittmer Ltd

Sidley Austin LLP

SKANDAMIS AVOCATS SA
Staiger Attorneys at Law Ltd

Tax Partner AG

Thouvenin Rechtsanwälte

VISCHER

Walder Wyss Ltd.

Wartmann Merker Ltd.

Wenger Plattner

Wenger Vieli Ltd

White & Case S.A.

Withers LLP
News & Developments
ViewPress Releases
Homburger advises Eli Lilly on the acquisition of LimmaTech Biologics
On May 26, 2026, Eli Lilly and Company (NYSE: LLY) announced the acquisition of LimmaTech Biologics AG for up to USD 780 m in cash, inclusive of an upfront payment and additional potential payments based upon the achievement of certain clinical and regulatory milestones. LimmaTech Biologics is developing vaccines against bacterial pathogens for which rising antimicrobial resistance is steadily closing therapeutic options.
The Homburger team advising Eli Lilly includes Anna Peter, Bianca Nedwed, Daniel Kuhn, Jana Waldvogel and Ivo Graf (all Corporate / M&A), Joel Fink (IP / IT), Jeremy Reichlin and Giulia Menegon (both Employment and Executive Compensation) as well as Stefan Oesterhelt and Juliette Buob (both Tax).
Contact
Wanda Schweda / Marketing / [email protected]
Homburger - May 28 2026
Press Releases
Homburger advised UBS AG, acting through its Stamford branch, on the establishment of a U.S. commercial paper program
On March 26, 2026, UBS AG, acting through its Stamford branch, successfully established a U.S. commercial paper program. The notes to be issued under the program will be offered pursuant to an exemption from registration under Section 4(a)(2) of the U.S. Securities Act of 1933, as amended (the «Securities Act»). The notes to be issued under the program will also be exempt from the registration requirements of the Securities Act pursuant to Section 3(a)(2) of the Securities Act and will be offered and sold pursuant to the exemption set forth in Section 16.5(b) of the securities offering regulations of the Office of the Comptroller of the Currency.
Homburger advised UBS AG with respect to all transactional aspects of Swiss law. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets) as well as Stefan Oesterhelt (Tax).
Contact
Wanda Schweda / Marketing / [email protected]
Homburger - May 27 2026
Press Releases
Bär & Karrer Advises on the Series A Financing Round of Swiss Bio-Materials Company Seprify
Bär & Karrer advises Inter IKEA Group in connection with its participation in the Series A financing round of Seprify AG. Seprify, the Swiss bio-materials company develops high-performance cellulose-based ingredients for industrial applications. The financing supports the transition of Seprify's cellulose platform from pilot validation into procurement-ready industrial supply.
Inter IKEA Group is the group of companies that connects IKEA franchisees with range development and suppliers, and aligns the overall IKEA strategic direction.
Bär & Karrer acts as legal advisor to Inter IKEA Group in this transaction. The team included Luca Jagmetti, Marlene Lienau Schindler and Ben Tschigg (all M&A/Corporate), Nicola Schön (Employment), and Mani Reinert and Martin P. Werner (both Competition & Antitrust).
For further information please contact:
Media Relations, Eric Stupp
Tel: +41 58 261 50 00
Email: [email protected]
Bär & Karrer is a leading Swiss law firm with more than 200 lawyers, providing customized legal advice in complex transactions and litigation. Clients range from multinational corporations to private individuals in Switzerland and abroad. Bär & Karrer is present with offices in all main language regions in Switzerland and operates globally via an international network of leading law firms. For further information please visit baerkarrer.ch.
Bär & Karrer Ltd. - May 22 2026
Press Releases
Homburger advised UBS, PostFinance and Sygnum in connection with a joint CHF stablecoin sandbox
On April 8, 2026, UBS, PostFinance, Sygnum, Raiffeisen, Zürcher Kantonalbank, BCV and Swiss Stablecoin AG announced the launch of a joint CHF stablecoin sandbox. The new initiative will test potential use cases for a CHF stablecoin in Switzerland. In doing so, the partners are exploring ways to connect blockchain applications with the Swiss franc, aiming to strengthen both the Swiss digital money ecosystem and the competitiveness of Switzerland’s financial center.
Homburger advised UBS, PostFinance and Sygnum with regard to contractual, corporate, regulatory and other legal aspects of the sandbox. The Homburger team was led by Dieter Gericke (Corporate / M&A) and Stefan Kramer (Financial Market Regulation / Investment Products) and included Daniel Bötticher and Constantin Khovrin (both Corporate / M&A) as well as Allegra Arnold (Competition) and Luca Dal Molin (IP / IT).
Contact
Beatrice Winkler / Marketing / [email protected]
Homburger - May 22 2026

